பித்தப்பை புற்றுநோய்

Evidence suggests distinct models of molecular and pathologic progression, and a growing body of genetics data points to a heterogeneous collection of underlying mutations in key oncogenes and tumor suppressor genes. Although tumor genetics have been used to tailor individual treatment regimens and guide clinical decision making in other cancers, these principles have not been applied in gallbladder malignancy. Recent clinical trials with targeted therapies seem promising, although the relationships between subsets of patients with positive responses to therapy and tumor genetics remain unexpl…

ஸ்பான்சர்: Banaras Hindu University
NCT05404347 on ClinicalTrials.gov
இந்த ரெஜிஸ்ட்ரியில் கடைசியாக 13 Aug 2024 அன்று அப்டேட் செய்யப்பட்டது · நாங்கள் 20 Oct 2026 அன்று பார்த்தோம்